SEC Form 8-K Summary
Registrant: Amplitude Healthcare Acquisition Corp. The provided metadata identifies Jasper Therapeutics, Inc., but the filing names Amplitude Healthcare Acquisition Corp. as the registrant.
Reporting date: December 1, 2020; filed December 3, 2020.
Business Context and Reporting Period
The company is a special purpose acquisition company whose securities were listed on Nasdaq. The filing concerns the scheduling and related nomination deadlines for its 2020 Annual Meeting of Stockholders.
Financial Metrics and Capital Structure
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics. It identifies the company’s listed units, Class A common stock, and warrants. Each warrant is exercisable for one share of Class A common stock at $11.50 per share.
Material Changes Versus Prior Period
The filing does not report financial or operating changes versus a prior comparable period. It announces that the 2020 Annual Meeting will be held on December 22, 2020.
Guidance, Outlook, Risks, and Unusual Items
- Stockholder proposals and director nominations were required to be delivered to the company’s principal executive offices no later than December 13, 2020.
- Before completion of the company’s initial business combination, holders of Class B common stock have the exclusive right to elect directors.
- Accordingly, only Class B common stockholders may nominate candidates for election as directors at the Annual Meeting.
- Proposals and nominations must also comply with Delaware law, SEC rules, and the company’s bylaws.
Important Facts for Investors to Verify
- Confirm whether this filing is intended to relate to Amplitude Healthcare Acquisition Corp. or Jasper Therapeutics, Inc.
- Review the definitive proxy statement for the Annual Meeting’s time, location, voting matters, and nomination procedures.
- Verify the rights and voting powers associated with Class A and Class B common stock before the initial business combination.
- Review subsequent filings for updates to the annual meeting, business combination status, trust assets, redemption terms, and warrant terms.